ATE352306T1 - Ein präkursor der harnsäure und ein antioxidationsmittel enthaltende zusammensetzung und deren verwendung zur behandlung von neurodegenerativen erkrankungen - Google Patents
Ein präkursor der harnsäure und ein antioxidationsmittel enthaltende zusammensetzung und deren verwendung zur behandlung von neurodegenerativen erkrankungenInfo
- Publication number
- ATE352306T1 ATE352306T1 AT99937735T AT99937735T ATE352306T1 AT E352306 T1 ATE352306 T1 AT E352306T1 AT 99937735 T AT99937735 T AT 99937735T AT 99937735 T AT99937735 T AT 99937735T AT E352306 T1 ATE352306 T1 AT E352306T1
- Authority
- AT
- Austria
- Prior art keywords
- uric acid
- antioxidant
- precursor
- treatment
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12718498A | 1998-07-31 | 1998-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE352306T1 true ATE352306T1 (de) | 2007-02-15 |
Family
ID=22428746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99937735T ATE352306T1 (de) | 1998-07-31 | 1999-08-02 | Ein präkursor der harnsäure und ein antioxidationsmittel enthaltende zusammensetzung und deren verwendung zur behandlung von neurodegenerativen erkrankungen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1100507B1 (de) |
JP (1) | JP2002521451A (de) |
AT (1) | ATE352306T1 (de) |
AU (1) | AU5250799A (de) |
CA (1) | CA2339004C (de) |
DE (1) | DE69934987T2 (de) |
ES (1) | ES2279627T3 (de) |
IL (2) | IL141160A0 (de) |
WO (1) | WO2000006171A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696485B1 (en) | 1996-04-02 | 2004-02-24 | Mars, Incorporated | Procyanidin and cyclo-oxygenase modulator compositions |
CN100548304C (zh) * | 2000-03-22 | 2009-10-14 | 马尔斯公司 | 应用与乙酰水杨酸联合的可可矢车菊苷配质作为抗血小板疗法 |
CA2304869A1 (en) * | 2000-04-07 | 2001-10-07 | Roman Rozencwaig | Method of medical treatment using uric acid or precursors thereof |
FR2808192A1 (fr) * | 2000-04-28 | 2001-11-02 | Oreal | Epichatechine comme inhibiteur de no-synthase et utilisations |
US6479547B1 (en) * | 2000-11-21 | 2002-11-12 | Arthur Vanmoor | Method of treating an infection by enhancing the effectiveness of the human immune system |
WO2002063982A1 (en) * | 2001-02-09 | 2002-08-22 | New Chapter, Inc. | Composition and method for smoke detoxification |
JP2002326922A (ja) * | 2001-03-01 | 2002-11-15 | Kose Corp | 皮膚外用剤 |
ITVR20010031A1 (it) * | 2001-03-12 | 2002-09-12 | Hisanori Suzuki | Uso di epigallocatechin-3-gallato o suoi derivati nella profilassi e nel trattamento delle malattie neurodegenerative. |
WO2009047639A2 (en) * | 2007-07-23 | 2009-04-16 | Keimyung University Industry Academic Cooperation Foundation | Epicatechin deficient green tea |
KR101694482B1 (ko) * | 2009-09-21 | 2017-01-10 | (주)아모레퍼시픽 | 녹차의 줄기세포를 함유하는 항산화 및 항노화용 화장료 조성물 |
US8916528B2 (en) | 2011-11-16 | 2014-12-23 | Resveratrol Partners, Llc | Compositions containing resveratrol and nucleotides |
CN105497355A (zh) * | 2015-07-23 | 2016-04-20 | 四川金堂海纳生物医药技术研究所 | 一种治疗破伤风的散剂药物及其制备方法 |
JP7333942B2 (ja) * | 2019-06-07 | 2023-08-28 | 株式会社スタージェン | 神経変性疾患に対するatp増強療法の効果を予測する方法 |
CN114377124B (zh) * | 2021-07-13 | 2023-08-25 | 中国医学科学院输血研究所 | 次黄嘌呤与注射用人免疫球蛋白的联合用药物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3380200D1 (en) * | 1982-09-16 | 1989-08-24 | William Alvin Carter | Anti-proliferative action of dsnras on tumor cells |
JPS60126220A (ja) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | 核酸成分組成物 |
US5043100A (en) * | 1987-07-23 | 1991-08-27 | Rutgers, The State University Of New Jersey | Process for manufacture of natural antioxidant products from tea and spent tea |
GB8918368D0 (en) * | 1989-08-11 | 1989-09-20 | Amco Chemie Gmbh | Compositions for treating obstructive airways disease |
LU87766A1 (fr) * | 1990-07-20 | 1992-03-11 | Oreal | Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre |
FR2692784B1 (fr) * | 1992-06-24 | 1995-06-30 | Pf Medicament | Utilisation de la guanosine, de ses precurseurs et ses derives pour la fabrication de medicaments destines a traiter les deficits fonctionnels cerebraux. |
US5391568A (en) * | 1992-07-10 | 1995-02-21 | American Health Foundation | Inhibition of lung tumorigenesis by administration of a polyphenol |
US5728707A (en) * | 1995-07-21 | 1998-03-17 | Constantia Gruppe | Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide |
BR9602919A (pt) * | 1996-06-27 | 1999-01-12 | Cosmeticos Natural Ind Com | Composições cosméticas para o cuidado da pele |
WO2000000212A1 (en) * | 1998-06-26 | 2000-01-06 | Nutracorp Scientific, Inc. | Promoting nitric oxide and cyclic gmp activity |
-
1999
- 1999-08-02 JP JP2000562025A patent/JP2002521451A/ja not_active Withdrawn
- 1999-08-02 CA CA002339004A patent/CA2339004C/en not_active Expired - Fee Related
- 1999-08-02 AT AT99937735T patent/ATE352306T1/de not_active IP Right Cessation
- 1999-08-02 EP EP99937735A patent/EP1100507B1/de not_active Expired - Lifetime
- 1999-08-02 WO PCT/US1999/017463 patent/WO2000006171A1/en active IP Right Grant
- 1999-08-02 ES ES99937735T patent/ES2279627T3/es not_active Expired - Lifetime
- 1999-08-02 DE DE69934987T patent/DE69934987T2/de not_active Expired - Lifetime
- 1999-08-02 AU AU52507/99A patent/AU5250799A/en not_active Abandoned
- 1999-08-02 IL IL14116099A patent/IL141160A0/xx unknown
-
2001
- 2001-01-29 IL IL141160A patent/IL141160A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU5250799A (en) | 2000-02-21 |
JP2002521451A (ja) | 2002-07-16 |
ES2279627T3 (es) | 2007-08-16 |
DE69934987T2 (de) | 2007-05-16 |
IL141160A (en) | 2009-11-18 |
EP1100507A1 (de) | 2001-05-23 |
EP1100507A4 (de) | 2002-07-31 |
IL141160A0 (en) | 2002-02-10 |
DE69934987D1 (de) | 2007-03-15 |
EP1100507B1 (de) | 2007-01-24 |
CA2339004C (en) | 2008-04-01 |
CA2339004A1 (en) | 2000-02-10 |
WO2000006171A1 (en) | 2000-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE352306T1 (de) | Ein präkursor der harnsäure und ein antioxidationsmittel enthaltende zusammensetzung und deren verwendung zur behandlung von neurodegenerativen erkrankungen | |
Liebmann et al. | Blue-light irradiation regulates proliferation and differentiation in human skin cells | |
BRPI0414455A (pt) | métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins | |
ATE423087T1 (de) | Proteasome inhibitoren und deren verwendung | |
ATE370225T1 (de) | Differenzierung von knochenmarkzellen in neuronale zellen und deren verwendungen | |
NO20050450L (no) | Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft | |
NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
BR9408025A (pt) | Compostos de peptidila e seu uso terapêutico como inibidores de metaloproteinases | |
EP2305276A3 (de) | Zellen aus Lipoaspirat und ihre Verwendung zur Therapie | |
ATE230394T1 (de) | Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen | |
ATE381336T1 (de) | Verwendung von a2a adenosin rezeptor agonisten und anti-pathogene mittel enthaltenden kombinationen zur behandlung von entzündungskrankheiten | |
DE69929810D1 (de) | Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion | |
ATE415962T1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
DE60027768D1 (de) | Behandlung von metastatischer krankheit | |
DE60026152D1 (de) | Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs | |
ATE113208T1 (de) | Verwendung des wirkstoffs azelastin zur bekämpfung von psoriasis-erkrankungen. | |
BR0015416A (pt) | Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos | |
EA200500849A1 (ru) | Новые соединения лапахона и способы их применения | |
NO20000784L (no) | Nye aggrecanaseinhibitorer og matriksmetalloproteinaser for behandling av artritt | |
ATE248592T1 (de) | Verwendung von naaladase hemmern zur herstellung eines medikaments zur behandlung von bestimmten krankheiten | |
EA199900542A1 (ru) | Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида | |
BR9912594A (pt) | Inibição de doença de enxerto versus hospedeiro | |
ATE311191T1 (de) | Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen | |
DE69227594D1 (de) | Verfahren zur erkennung und behandlung anomaler zellen | |
ATE250427T1 (de) | Zusammensetzungen und deren verwendung zur hemmung von angiogenese |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |